Upexi (NASDAQ:UPXI) CEO Allan Marshall Acquires 100,000 Shares

Upexi, Inc. (NASDAQ:UPXI) CEO Allan Marshall acquired 100,000 shares of the company’s stock in a transaction dated Monday, December 15th. The stock was acquired at an average cost of $2.07 per share, with a total value of $207,000.00. Following the purchase, the chief executive officer owned 3,946,261 shares of the company’s stock, valued at approximately $8,168,760.27. This trade represents a 2.60% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website.

Allan Marshall also recently made the following trade(s):

• On Tuesday, December 16th, Allan Marshall purchased 50,000 shares of Upexi stock. The shares were purchased at an average price of $2.07 per share, with a total value of $103,500.00.

Upexi Price Performance

Shares of Upexi stock traded up $0.11 during trading hours on Thursday, reaching $1.98. The company’s stock had a trading volume of 1,392,203 shares, compared to its average volume of 4,132,947. The stock has a market cap of $124.84 million, a P/E ratio of -0.47 and a beta of -0.52. Upexi, Inc. has a one year low of $1.86 and a one year high of $22.57. The company has a debt-to-equity ratio of 0.68, a current ratio of 3.41 and a quick ratio of 3.39. The firm has a 50 day moving average price of $3.69 and a 200-day moving average price of $5.73.

Upexi (NASDAQ:UPXI) last posted its quarterly earnings data on Wednesday, November 12th. The company reported ($0.12) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.11). The firm had revenue of $9.24 million for the quarter, compared to analysts’ expectations of $7.33 million. Upexi had a negative return on equity of 30.42% and a net margin of 264.25%.

Upexi announced that its Board of Directors has authorized a share buyback plan on Thursday, November 13th that permits the company to buyback $50.00 million in shares. This buyback authorization permits the company to purchase up to 25.1% of its shares through open market purchases. Shares buyback plans are often an indication that the company’s leadership believes its stock is undervalued.

Hedge Funds Weigh In On Upexi

A number of institutional investors have recently modified their holdings of the stock. BlueCrest Capital Management Ltd acquired a new stake in Upexi during the third quarter worth about $407,000. Heights Capital Management Inc. acquired a new stake in shares of Upexi during the 3rd quarter worth approximately $1,442,000. Alyeska Investment Group L.P. purchased a new position in shares of Upexi during the 3rd quarter valued at approximately $7,175,000. Nomura Holdings Inc. acquired a new position in shares of Upexi in the 3rd quarter valued at $104,000. Finally, Clear Street Group Inc. purchased a new stake in Upexi during the third quarter worth $104,000. Hedge funds and other institutional investors own 5.68% of the company’s stock.

Wall Street Analyst Weigh In

UPXI has been the topic of a number of analyst reports. Cantor Fitzgerald cut their price target on Upexi from $16.00 to $6.00 and set an “overweight” rating on the stock in a report on Friday, November 14th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Upexi in a report on Monday. Finally, Wall Street Zen raised Upexi from a “sell” rating to a “hold” rating in a research report on Tuesday. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Upexi presently has a consensus rating of “Hold” and an average target price of $10.50.

Upexi Company Profile

Upexi, Inc manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc and changed its name to Upexi, Inc in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.